Dr. Mark Paul Leischner , MD
Internal Medicine - Nephrology • Chicago, IL
2608 W Addison St
Chicago, IL 606185905
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Mark Leischner is listed in NPPES under Internal Medicine - Nephrology.
-
NPI assigned on June 14, 2006; this date does not establish years in practice.
-
Published CMS data list 10,734 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- Q9967 — Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml: 8,660 service units.
- J3010 — Injection, fentanyl citrate, 0.1 mg: 456 service units.
- 99214 — Established patient outpatient office visit: 322 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 14 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 1,150 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Calcitriol — 235 prescription fills, including refills.
- Furosemide — 113 prescription fills, including refills.
- Amlodipine Besylate — 78 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 27 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 95% of clinicians listed under Internal Medicine - Nephrology in Chicago, IL (2024, 128 clinicians with data). Median for this group: 630. Middle half: 275 to 1,075.
More Medicare Part B services than 95% of clinicians listed under Internal Medicine - Nephrology in Illinois (2024, 421 clinicians with data). Median for this group: 1,449. Middle half: 649 to 2,433.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 9,102 in 2020 to 10,734 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
2608 W Addison St
Chicago, IL 606185905
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Associates In Nephrology Sc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Loyola University Of Chicago, Stritch School Of Medicine
2001
What Public CMS Data Show
Internal Medicine - Nephrology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
427 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $270,328 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $204,607 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
2,495 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$273,245 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $313.51 across 14 records.
By nature of payment
- Food and Beverage: $313.51 across 14 records.
Reporting-company totals (3 largest of 7)
- Fresenius USA Marketing, Inc.: $73.38 across 3 records.
- Calliditas Therapeutics US Inc.: $70.36 across 3 records.
- AstraZeneca Pharmaceuticals LP: $50.09 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
25 years (graduated 2001)
CMS Doctors and Clinicians data list 2001 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Leischner has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Leischner as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Chicago and Illinois
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 95% of clinicians listed under Internal Medicine - Nephrology in Chicago, IL (2024, 128 clinicians with data). Median for this group: 630. Middle half: 275 to 1,075.
More Medicare Part B services than 95% of clinicians listed under Internal Medicine - Nephrology in Illinois (2024, 421 clinicians with data). Median for this group: 1,449. Middle half: 649 to 2,433.
Medicare-allowed amount
A higher Medicare-allowed amount than 90% of clinicians listed under Internal Medicine - Nephrology in Chicago, IL (2024, 128 clinicians with data). Median for this group: $70,354. Middle half: $28,242 to $147,497.
A higher Medicare-allowed amount than 70% of clinicians listed under Internal Medicine - Nephrology in Illinois (2024, 421 clinicians with data). Median for this group: $180,790. Middle half: $70,368 to $271,488.
Paid by Medicare
A higher Medicare payment amount than 90% of clinicians listed under Internal Medicine - Nephrology in Chicago, IL (2024, 128 clinicians with data). Median for this group: $55,960. Middle half: $22,479 to $114,110.
A higher Medicare payment amount than 70% of clinicians listed under Internal Medicine - Nephrology in Illinois (2024, 421 clinicians with data). Median for this group: $139,756. Middle half: $55,980 to $207,698.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Internal Medicine - Nephrology in Chicago, IL (2024, 134 clinicians with data). Median for this group: 314. Middle half: 84 to 621.
More Part D prescriptions than 65% of clinicians listed under Internal Medicine - Nephrology in Illinois (2024, 433 clinicians with data). Median for this group: 642. Middle half: 250 to 1,382.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Internal Medicine - Nephrology in Chicago, IL (2024, 134 clinicians with data). Median for this group: $41,472. Middle half: $5,830 to $115,559.
A higher Part D drug cost than 80% of clinicians listed under Internal Medicine - Nephrology in Illinois (2024, 433 clinicians with data). Median for this group: $93,430. Middle half: $27,376 to $215,537.
197 active clinicians are listed under Internal Medicine - Nephrology with a practice address in Chicago, IL (575 in Illinois).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Chicago
25.4% of these 197 clinicians have the CMS telehealth indicator.
66.5% of these 197 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 18% from 9,102 in 2020 to 10,734 in 2024.
- 2020: 9,102
- 2021: 8,141
- 2022: 7,308
- 2023: 6,285
- 2024: 10,734
-
Medicare-allowed amount
Medicare-allowed amount decreased 44% from $479,284 in 2020 to $270,328 in 2024.
- 2020: $479,284
- 2021: $500,240
- 2022: $433,821
- 2023: $308,556
- 2024: $270,328
-
Paid by Medicare
Paid by Medicare decreased 46% from $378,676 in 2020 to $204,607 in 2024.
- 2020: $378,676
- 2021: $397,861
- 2022: $337,892
- 2023: $239,980
- 2024: $204,607
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 116% from 533 in 2020 to 1,150 in 2024.
- 2020: 533
- 2021: 718
- 2022: 906
- 2023: 1,148
- 2024: 1,150
-
30-day fills
30-day fills increased 114% from 1,165 in 2020 to 2,495 in 2024.
- 2020: 1,165
- 2021: 1,619
- 2022: 1,933
- 2023: 2,294
- 2024: 2,495
-
Part D drug cost
Part D drug cost increased 481% from $46,994 in 2020 to $273,245 in 2024.
- 2020: $46,994
- 2021: $55,931
- 2022: $176,141
- 2023: $258,249
- 2024: $273,245
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $134.86 in 2021 to $313.51 in 2025.
- 2021: $134.86
- 2022: $142.62
- 2023: $311.15
- 2024: $186.16
- 2025: $313.51
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 14 records totaling $313.51.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $30.34 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $29.76 |
| Calliditas Therapeutics US Inc. |
Food and Beverage
In-kind items and services
|
TARPEYO | General | $27.79 |
| Fresenius USA Marketing, Inc. |
Food and Beverage
In-kind items and services
|
VELPHORO | General | $24.69 |
| Fresenius USA Marketing, Inc. |
Food and Beverage
In-kind items and services
|
VELPHORO | General | $24.37 |
| Fresenius USA Marketing, Inc. |
Food and Beverage
In-kind items and services
|
VELPHORO | General | $24.32 |
| Calliditas Therapeutics US Inc. |
Food and Beverage
In-kind items and services
|
TARPEYO | General | $21.82 |
| Calliditas Therapeutics US Inc. |
Food and Beverage
In-kind items and services
|
TARPEYO | General | $20.75 |
| Aurinia Pharma U.S., Inc. |
Food and Beverage
In-kind items and services
|
LUPKYNIS | General | $20.59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $19.85 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $19.75 |
| Travere Therapeutics, Inc. |
Food and Beverage
In-kind items and services
|
— | General | $19.35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JARDIANCE | General | $16.28 |
| Aurinia Pharma U.S., Inc. |
Food and Beverage
In-kind items and services
|
LUPKYNIS | General | $13.85 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
Q9967
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
|
8,660 | 109 | $0.50 | $0.13 |
|
J3010
Injection, fentanyl citrate, 0.1 mg
|
456 | 77 | $2.00 | $0.90 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
322 | 157 | $331.00 | $90.80 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
311 | 151 | $42.00 | $15.72 |
|
J2250
Injection, midazolam hydrochloride, per 1 mg
|
254 | 78 | $2.00 | $0.14 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
161 | 69 | $206.00 | $75.21 |
|
90960
Dialysis services, 4 or more physician visits per month (20 years or older)
|
129 | 19 | $907.00 | $334.49 |
|
99152
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes
|
103 | 70 | $131.00 | $47.25 |
|
36902
Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist
|
87 | 62 | $3143.00 | $1121.83 |
|
90961
Dialysis services, 2-3 physician visits per month (20 years or older)
|
73 | 25 | $754.00 | $277.46 |
|
36901
Insertion of needle and/or tube into hemodialysis circuit with review by radiologist
|
62 | 49 | $1844.00 | $658.74 |
|
99222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
|
44 | 40 | $340.00 | $126.06 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
42 | 42 | $437.00 | $163.16 |
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
30 | 17 | $309.00 | $113.65 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Calcitriol | Calcitriol | 235 | 14,234 | $3,997.44 | 62 |
| Furosemide | Furosemide | 113 | 7,621 | $822.91 | 32 |
| Amlodipine Besylate | Amlodipine Besylate | 78 | 5,734 | $531.16 | 29 |
| Farxiga | Dapagliflozin Propanediol | 74 | 3,300 | $62,700.35 | 19 |
| Nifedipine Er | Nifedipine | 72 | 5,274 | $1,891.18 | 20 |
| Jardiance | Empagliflozin | 67 | 2,826 | $56,159.39 | 13 |
| Losartan Potassium | Losartan Potassium | 53 | 4,247 | $386.21 | 21 |
| Carvedilol | Carvedilol | 39 | 3,059 | $337.59 | 14 |
| Sevelamer Carbonate | Sevelamer Carbonate | 39 | 2,490 | $6,989.37 | 17 |
| Lisinopril | Lisinopril | 38 | 3,060 | $242.30 | 18 |
| Atorvastatin Calcium | Atorvastatin Calcium | 38 | 2,970 | $250.66 | 14 |
| Hydrochlorothiazide | Hydrochlorothiazide | 34 | 2,560 | $285.90 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 28 | 1,200 | $264.00 | — |
| Gabapentin | Gabapentin | 26 | 1,200 | $434.99 | — |
| Allopurinol | Allopurinol | 23 | 1,520 | $106.38 | — |
| Famotidine | Famotidine | 23 | 1,560 | $171.07 | — |
| Enalapril Maleate | Enalapril Maleate | 20 | 1,609 | $421.96 | — |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 18 | 768 | $1,233.03 | — |
| Metoprolol Succinate | Metoprolol Succinate | 17 | 1,290 | $233.59 | — |
| Calcium Acetate | Calcium Acetate | 17 | 1,410 | $1,813.55 | — |
| Bumetanide | Bumetanide | 16 | 1,320 | $851.32 | — |
| Velphoro | Sucroferric Oxyhydroxide | 16 | 600 | $80,881.16 | — |
| Clonidine Hcl | Clonidine Hcl | 15 | 1,170 | $314.85 | — |
| Cinacalcet Hcl | Cinacalcet Hcl | 15 | 1,044 | $3,745.28 | — |
| Nulojix | Belatacept | 13 | 337 | $47,476.71 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2024-11-22NUCC Taxonomy Code: 207RN0300X
An internist who treats disorders of the kidney, high blood pressure, fluid and mineral balance and dialysis of body wastes when the kidneys do not function. This specialist consults with surgeons about kidney transplantation.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NEPHROLOGY
I20060622000056
IL
0547272288
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Associates In Nephrology Sc
215 S Aberdeen St, Chicago, IL 606072901
Phone: 3127337335
Associates In Nephrology Sc
2233 W Division St, Chicago, IL 606228151
Phone: 3127702000
Associates In Nephrology Sc
2608 W Addison St, Chicago, IL 606185905
Phone: 7737563333
Associates In Nephrology Sc
2620 W Addison St, Chicago, IL 606185905
Phone: 7732480462
Associates In Nephrology Sc
2900 N Lake Shore Dr, Chicago, IL 606575640
Phone: 7736653000
Associates In Nephrology Sc
331 W Surf St, Chicago, IL 606577227
Phone: 7735254501
Associates In Nephrology Sc
4800 N Kilpatrick Ave, Chicago, IL 606301725
Phone: 7735453693
Associates In Nephrology Sc
5145 N California Ave, Chicago, IL 606253661
Phone: 7738788200
Associates In Nephrology Sc
825 W 35th St, Chicago, IL 606091511
Associates In Nephrology Sc
850 W Irving Park Rd, Chicago, IL 606133077
Phone: 3126542721
Associates In Nephrology Sc
9000 S Stony Island Ave, Chicago, IL 606173508
Phone: 7735254501
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Obstetrics & Gynecology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
NPI status registered as active in NPPES database
Registered at 2608 W ADDISON ST, CHICAGO, IL 606185905 (Tel: 7737563333)
Registered at 210 S DESPLAINES ST, CHICAGO, IL 606615500 (Tel: 3126542700)
Recorded as MARK LEISCHNER, M.D.
Internal Medicine (license number reported to NPPES: IL 036110702)
NPI status registered as active in NPPES database
Registered at 2800 N SHERIDAN RD, SUITE 304, CHICAGO, IL 606576156 (Tel: 7735254501)
Registered at 210 S DESPLAINES ST, CHICAGO, IL 606615500 (Tel: 3126542700)
Recorded as MARK LEISCHNER, M.D.
Internal Medicine (license number reported to NPPES: IL 036110702)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine - Nephrology Specialists in Chicago
- Dr. Malgorzata Patro, MD
- Dr. Vedvati Patel, MD
- Elaine Worcester
- Dr. Juan Jose Cintron Garcia, MD, MPH
- Dr. Gautam Bhanushali, MD
- Dr. Miguel Manrique Palaviccini, MD
Mailing Address
210 S Desplaines St
Chicago, IL 606615500
Phone: 3126542700